Targeted therapies for bone regeneration to treat age-related bone loss
Total raised: $8M
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.11.2025 | - | $8M | - |
Mentions in press and media 2
| Date | Title | Description |
| 17.11.2025 | Skeletalis Raises $8M in Funding | Skeletalis, a Boston, MA-based drug development company focused on new therapies for treating musculoskeletal diseases, raised $8m in funding. The round was led by Pillar VC with participation from KdT Ventures, age1, and Slocum Management.... |
| - | Skeletalis | “We’re translating insights in bone biology into targeted therapies that protect and rebuild bone—without shutting down the body’s natural bone remodeling.” |